| Description | Purity: > 95% by SDS - PAGE Format: Liquid. In 20mM Tris-HCl buffer (pH7.5) containing 1mM DTT, 10% glycerol . Non-metastatic cells 1 (NME1), also known as NM23-H1, originally identified as a candidate metastasis suppressor gene. NME1 is expressed in different tumor types where their levels have been alternatively associated with reduced or increased metastatic potential. Reductions in NME1 expression have been significantly associated with aggressive behavior in melanoma, breast, colon, and gastric carcinomas. On the contrary, high levels of NME1 gene expression are noted in the advanced stage of thyroid carcinomas. Recombinant human NME1 was expressed in E.coli and purified by using conventional chromatography techniques. |
|---|
| Other Names | Non-metastatic cells 1, Nucleoside diphosphate kinase A, NDP kinase A, AWD, GAAD, NB, NBS, NDPK-A, NM23, NM23-H1, Non-metastatic cells 1 AWD, drosophila, homolog of, NDPKA, NM23, NM23-M1, Granzyme A activated DNase, GZMA activated DNase, Metastasis inhibition factor nm23, NDK A, NDP Kinase A, NM23 long variant, included, Nonmetastatic protein 23, NME1-NME2 spliced read-through transcript, included, Non-metastatic cells 1, protein (NM23A) expressed in, Nonmetastatic cells 1, protein expressed in, NME1, Nucleoside diphosphate kinase A, Nonmetastatic protein 23, homolog 1, NM23H1B, included, Tumor metastatic process-associated protein. |
|---|